SCHEMBL31444360

SCHEMBL31444360

CC(C)(C)OC(=O)NCc1ccccc1C(O)c1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.47
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
ATM Q13315 1/20 0.44
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4A O75164 1/20 0.43
NPC1 O15118 2/20 0.42
FDFT1 P37268 2/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 2/20 0.42
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41
HIF1A Q16665 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26147436 0.84 NPC1 (0.60) KCNA5POLBMAPK1ATMMEN1
SCHEMBL6190137 0.83 KCNA5 (0.44) KCNA5POLBMAPK1ATMMEN1
SCHEMBL6189254 0.83 KCNA5 (0.41) KCNA5POLBMAPK1ATMMEN1
SCHEMBL12743180 0.81 KCNA5 (0.55) KCNA5ATMKDM4AHDAC10HDAC6
SCHEMBL17018542 0.81 KCNA5 (0.52) KCNA5KDM4AHDAC10HDAC6
SCHEMBL17018550 0.81 KCNA5 (0.52) KCNA5KDM4AHDAC10HDAC6
SCHEMBL17018553 0.81 KCNA5 (0.52) KCNA5KDM4AHDAC10HDAC6
SCHEMBL12578890 0.81 KCNA5 (0.49) KCNA5POLBATMLMNAKDM4A
SCHEMBL17018470 0.81 KCNA5 (0.52) KCNA5KDM4AHDAC10HDAC6
SCHEMBL6187411 0.80 FDFT1 (0.40) KCNA5POLBMAPK1ATMKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072451-A1 RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES VIVIDION THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed